InterSol (Fenwal, Inc.)
Welcome to the PulseAid listing for the InterSol drug offered from Fenwal, Inc.. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fenwal, Inc. |
| NON-PROPRIETARY NAME: | Platelet Additive 3 |
| SUBSTANCE NAME: | SODIUM CHLORIDE; SODIUM ACETATE; TRISODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-10-25 |
| END MARKETING DATE: | 0000-00-00 |
InterSol HUMAN PRESCRIPTION DRUG Details:
| Item Description | InterSol from Fenwal, Inc. |
| LABELER NAME: | Fenwal, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 452; 442; 318; 305; 93(mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL) |
| START MARKETING DATE: | 2012-10-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0942-9601_8f548120-da1d-4bcd-bcbe-2fed425d842c |
| PRODUCT NDC: | 0942-9601 |
| APPLICATION NUMBER: | BN080041 |
Other SODIUM CHLORIDE; SODIUM ACETATE; TRISODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Pharmaceutical Manufacturers / Labelers:
